Cited by 138Computational Drug Discovery MethodsData Mining Algorithms and ApplicationsAI-based Problem Solving and Planning

The DOI matches its Crossref record; the references it cites are not checked yet.

Pharmacophore Discovery Using the Inductive Logic Programming System PROGOL

Open access

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1023/a:1007460424845

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • ILP has been applied to identifying and predicting ligands.

    “The types of task ILP has been applied to include identifying and predicting ligands (substructures responsible for medical activity) (Finn et al., 1998; Srinivasan et al., 2006; Kaalia et al., 2016)”

    From Inductive Logic Programming At 30: A New Introduction (2022) · cites this paper as Finn et al., 1998

    Section 2.2.3 (page unavailable) says the paper applies ILP to pharmacophore discovery, identifying molecular features associated with biological activity. Section 2.3 (page unavailable) also describes ILP applications to predicting molecular activity. But the paper defines ligands as molecules that bind to a protein, not as activity-related substructures, and does not describe its task as predicting ligands. (LLM, conf=0.87)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

The citation lists haven’t been fetched yet

References 34 · Cited by 138

Research works printed but not linked: 28

  1. Andrews, P., Carson, J., Caselli, A., Spark, M., & Woods, R. (1985). Conformational analysis and active site modelling of angiotensin-converting enzyme inhibitors. Journal of Medicinal Chemistry, 28:393–399. · DOI
  2. Bohacek, R., Lombaert, S. D., McMartin, C., Priestle, J., & Grutter, M. (1996). Three-dimensional models of ACE and NEP inhibitors and their use in the design of potent dual ACE/NEP inhibitors. Journal of the American Chemical Society, 118:8231–8249. · DOI
  3. Brint, A. & Willett, P. (1987). Algorithms for the identification of three-dimensional maximal common substructures. J. Chem. Inf. Comput. Sci., 27(152):152–158. · DOI
  4. Buchanan, B., Feigenbaum, E., & Sridharan, N. (1972). Heuristic theory formation: data interpretation and rule formation. In Meltzer, B. and Michie, D., editors, Machine intelligence 7, pages 267–290. Edinburgh University Press.
  5. Debnath, A., de Compadre, R. L., Debnath, G., Schusterman, A., & Hansch, C. (1991). Structure-activity relationship of mutagenic aromatic and heteroaromatic nitro compounds. correlation with molecular orbital energies and hydrophobicity. Journal of Medicinal Chemistry, 34(2):786–797. · DOI · Paper page
  6. Dietterich, T., Lathrop, R., & Lozano-Perez, T. (1997). Solving the multiple-instance problem with axis-parallel rectangles. Artificial Intelligence, 89(1-2):31–71. · DOI · Paper page
  7. Fayyad, U., Piatetsky-Shapiro, G., Smyth, P., & Uthurusamy, R. (1996). Advances in knowledge discovery and data mining. AAAI Press / MIT Press.
  8. Finn, P. (1996). Computer-based screening of compound databases for the indentification of novel leads. Drug Discovery Today, 1:363–370. · DOI
  9. Hassell, C., Krohn, A., Moody, C., & Thomas, W. (1982). The design of a new group of angiotensin-converting enzyme inhibitors. FEBS Letters, 147:175–179. · DOI
  10. Jain, A., Dietterich, T., Lathrop, R., Chapman, D., Critchlow, R., Bauer, B., Webster, T., & Lozano-Pérez, T. (1994a). Compass: a shape-based machine learning tool for drug design. Journal of Computer-Aided Molecular Design, 8:635–652. · DOI
  11. Jain, A., Koile, K., Bauer, B., & Chapman, D. (1994b). Compass: Predicting biological activities from molecular surface properties. Journal of Medicinal Chemistry, 37:2315–2327. · DOI
  12. King, R., Muggleton, S., Lewis, R., & Sternberg, M. (1992). Drug design by machine learning: The use of inductive logic programming to model the structure-activity relationships of trimethoprim analogues binding to dihydrofolate reductase. Proceedings of the National Academy of Sciences, 89(23):11322–11326. · DOI · Paper page
  13. King, R., Muggleton, S., Srinivasan, A., & Sternberg, M. (1996). Structure-activity relationships derived by machine learning: the use of atoms and their bond connectives to predict mutagenicity by inductive logic programming. Proceedings of the National Academy of Sciences, 93:438–442. · DOI
  14. Leach, A. (1991). A survey of methods for searching conformational space of small and medium sized molecules. In Lipkowitz and Boyd, editors, Reviews of Computational Chemistry, Vol. 2. VCH USA. · DOI
  15. Lee, Y., Buchanan, B., & Aronis, J. (1998). Knowledge-based learning in exploratory science: Learning rules to predict rodent carcinogenicity. Machine Learning, 30, 217–240. · DOI
  16. Lombaert, S. D., Chatelain, R., Fink, C., & Trapani, A. (1996). Design and pharmacology of dual angiotensinconverting enzyme and neutral endopeptidase inhibitors. Current Pharmaceutical Design, 2:443–462. · DOI
  17. Martin, Y., Bures, M., Danaher, E., DeLazzer, J., Lico, I., & Pavlik, P. (1993). A fast new approach to pharmacophore mapping and its application to dopaminergic and benzodiazepine agonists. Journal of Computer-Aided Molecular Design, 7:83–102. · DOI
  18. Mayer, D., Naylor, C., Motoc, I., & Marshall, G. (1987). A unique geometry of the active site of angiotensinconverting enzyme consistent with structure-activity studies. Journal of Computer-Aided Molecular Design, 1:3–16. · DOI
  19. Michalski, R., Mozetic, I., Hong, J., & Lavrac, N. (1986). The AQ15 inductive learning system: an overview and experiments. In Proceedings of IMAL 1986, Orsay. Université de Paris-Sud.
  20. Muggleton, S. (1995). Inverse entailment and Progol. New Generation Computing, 13:245–286. · DOI · Paper page
  21. Muggleton, S. (1996). Learning from positive data. In Proceedings of the Sixth Inductive Logic Programming Workshop, Lecture notes in artificial intelligence, Berlin. Springer-Verlag.
  22. Muggleton, S. & Feng, C. (1990). Efficient induction of logic programs. In Proceedings of the First Conference on Algorithmic Learning Theory, Tokyo. Ohmsha.
  23. Muggleton, S., Page, C., & Srinivasan, A. (1996). An initial experiment into stereochemistry-based drug design using ILP. In Proceedings of the Sixth Inductive Logic Programming Workshop, Lecture notes in artificial intelligence, Berlin. Springer-Verlag.
  24. Provost, F. & Aronis, J. (1996). Scaling up inductive learning with massive parallelism. Machine Learning, 23:33–46. · DOI
  25. Shapiro, E. (1983). Algorithmic program debugging. MIT Press. · DOI · Paper page
  26. Srinivasan, A. & Camacho, R. (1996). Experiments in numerical reasoning with ILP. Technical Report PRGTR-22-96, Oxford University Computing Laboratory, Oxford.
  27. Srinivasan, A. & Camacho, R. (1997). Experiments in numerical reasoning with ILP. Journal of Logic Programming (accepted).
  28. Whittle, P. & Blundell, T. (1994). Protein structure-based drug design. Annu. Rev. Biophys. Biomol. Struct., 23:349–375. · DOI

Metadata

Authors
Finn, P., Muggleton, S., Page, D., & Srinivasan, A.
Affiliations
  • Pfizer (United Kingdom) (GB)
  • University of York (GB)
  • University of Louisville (US)
  • University of Oxford (GB)
Venue
Machine Learning
Published
1998-02
Volume
30
Issue
2-3
Pages
241-270
ISSN
  • 0885-6125 (ISSN-L)
  • 1573-0565
OpenAlex
W1534731256
Cited by
138
References
34
Citations by year
2026: 1 · 2025: 2 · 2024: 1 · 2022: 1 · 2021: 1 · 2020: 1 · 2019: 4 · 2018: 1 · 2017: 2 · 2016: 1 · 2015: 1 · 2014: 2 · 2013: 9 · 2012: 4
FWCI
13.11
Type
journal article
Language
en
Open access
Locations
Machine Learning (publishedVersion)
Funders
  • Pfizer
  • University of Oxford
  • Engineering and Physical Sciences Research Council
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
  • Physical Sciences › Computer Science › Information Systems › Data Mining Algorithms and Applications
  • Physical Sciences › Computer Science › Artificial Intelligence › AI-based Problem Solving and Planning
Keywords
inductive logic programming, Progol, ACE inhibitors, drug design, knowledge discovery, hypothesis search, declarative knowledge representation, prior knowledge

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review